Efficacy of endoscopic screening for esophageal cancer is not sufficiently definitive and lacks randomized controlled trial evidence. The present study proved short-term screening efficacy through describing and comparing disease stage distributions of intervention and control populations. Villages from Linzhou and Cixian were cluster randomly allocated to the intervention or to the control group and the target population of 52 729 and 43 068 individuals was 40-69 years old, respectively, and the actual enrolled numbers were 18 316 and 21 178, respectively. TNM stage information and study-defined stage information of esophageal cases from 2012 to 2016 were collected. Stage distributions were compared between the intervention and control groups in the total target population, as well as in the subgroup populations in terms of enrolment and before or after intervention. There were a total of 199 and 141 esophageal cancer cases in the intervention and control groups, respectively. For the target population, distributions of TNM stage were borderline significant between the two groups after intervention (P = .093). However, subgroup analysis of the enrolled population during the after-intervention period had statistical significance for both TNM and study-defined stage. Natural TNM stage distributions were approximately 32%, 41%, 24% and 3% for stages I to IV vs 71%, 19%, 7% and 3% in the intervention population. The natural study-defined stage distributions from early, middle to advanced stages were approximately 18%, 49% and 33% vs 59%, 33% and 8%. Early-stage esophageal cancer cases accounted for a higher proportion after endoscopy screening, and the efficacy in the target population depends on the intervention compliance.
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| INTRODUCTION
As the eighth most common cancer and the sixth most common cause of cancer death in the world, esophageal cancer has a severe disease burden with annually about 456 000 new cases and 400 000 deaths. 1 As for China, which accounts for nearly 50% of esophageal cancer cases worldwide, 2 estimation of new cases and deaths in 2013 were 277 000 and 206 000 respectively, 3 and most cases are squamous cell carcinoma. As a result of limited knowledge and methods for etiology prevention, secondary prevention is the major approach to esophageal cancer prevention and control, especially for ESCC. In order to detect cancer early and improve prognosis, screening by endoscopy with iodine staining has been the major secondary prevention measure in China. Meanwhile, the efficacy of endoscopy screening has been confirmed by a long-term follow-up cohort study, 4 but lack of randomization meant that the conclusion was not sufficiently definitive.
Cancer registry is an effective way to monitor cancer incidence, for which doctors recommended radiotherapy or chemotherapy but this was not followed, and cases that left hospital without any treatment or reasons.
| Statistical analysis
All statistical analyses were carried out through SAS 9. (Table 3) , still without statistical significance (P = .296).
In the subgroup analysis in which the population was divided into enrolled or non-enrolled populations and time was divided into before-intervention and after-intervention, TNM stage distributions of intervention and control groups had statistical significance in the enrolled population during the after-intervention (P = .006) and total periods only (P = .022), as well as borderline significance in total target population during the after-intervention period (P = .093). As for study-defined stage, distributions of the 2 groups were also statistically significant in the enrolled population during the after-intervention (P < .001) and total periods (P < .001), as well as in the total target population during the after-intervention period (P = .047). The few cases in the enrolled intervention group during the before-intervention period did not allow a comparison to be made.
The above results showed that the stage distributions of the intervention group and the control group in the non-enrolled population could be considered the same, and the control group in the enrolled population was without intervention, so we combined their stage distribution data to estimate the stage distribution proportions in the natural population. The estimations were about 32%, 41%, 24% and 3%, respectively, for stages I to IV vs 71%, 19%, 7% and 3% in the enrolled intervention group during the after-intervention period ( Figure 2 ). The estimation for study-defined stage Each cell contains number of cases and its column proportion, which is same in Table 3 .
T A B L E 3 Comparison of study-defined stage distributions between intervention and control groups
Before-intervention After-intervention Total Including stages IIIb, IIIc and IV cases determined by TNM stage criteria, cases having radiotherapy or chemotherapy only but without any surgery records, cases for which doctors recommended radiotherapy or chemotherapy but this was not followed, and cases that left hospital without any treatment or reasons.
distributions were about 18%, 49% and 33% from early to advanced stage vs 59%, 33% and 8% in the enrolled intervention group during the after-intervention period (Figure 3 ).
| DISCUSSION
As an invasive early examination, endoscopy screening for esophageal cancer was generally considered controversial, 12 but that depends on factors discussed below. For EAC and Barrett's esophagus, evidence from population-based cohort studies have supported the decrease of mortality and better survival by endoscopy screening. 13, 14 However, there is a lack of RCT to prove efficacy. Furthermore, cost-effectiveness or cost-utility models showed that current surveillance programs do more harm than good. 15, 16 For ESCC and dysplasia, endoscopy screening has proven both a decrease in incidence and mortality through a population-based cohort study, 4 and health economics studies support screening in high-risk areas in China. 17, 18 However, with different health economics results, both pathological categories tend to support the effectiveness of endoscopy screening, but still need RCT to draw final conclusions. As individual randomization was not feasible, cluster randomization was used in this study. Disease stage was taken as the short-term endpoint because follow up has just started and the mortality data are not currently available, as it is well associated with prognosis. group. This should mainly be because of many preclinical phase cases that were detected before symptoms appeared through endoscopy screening. We also expected that the screening intervention may at least bring the consciousness of esophageal cancer prevention to the non-enrolled intervention group population although they were not enrolled. However, in terms of periods and whether enrolled or not, the other subgroups all showed no statistical significance between the 2 groups. This means that the screening effect was only reflected in the enrolled population and had no influence on the non-enrolled population. Furthermore, the statistical significance of the enrolled population during the total period and the total target population during the after-intervention period also mainly resulted from the enrolled population during the after-intervention period. Hence, the viewpoint that the efficacy of screening intervention depends on population compliance. Going back to the total target populations results, it was the high proportion of the nonenrolled population that diluted the total effect. Screening compliance in China is not always very high 19 and is hard to improve, which restricts the expanding of intervention effects. Moreover, as endoscopy screening always costs much in the way of resources, risk stratification and more precise selection of intervention subjects should be another effective way to improve screening efficacy beyond the compliance improvement. Actually, this will not only increase the screening efficacy, but also leave a greater number of normal subjects without harm from endoscopy, and it is applicable for EAC to change the previous poor efficiency surveillance programs.
In our study, it is unavoidable to face the reality that the mere approximately 50% integrality of TNM stage information may lead to conclusions with obvious selection bias. The low integrality of However, the reality of the few esophageal cases in the enrolled intervention group population prevented the plan from proceeding.
This may be because of inability to enrol as a result of death or unwillingness to enrol into the intervention group after treatment.
Therefore, these were the actual real-world results.
When comparing baseline information between enrolled intervention and control group populations, several meaningful differences deserve our attention. First is the gender imbalance, showing a higher percentage of females in the intervention group (59.06%) than in the control group (54.99%). As our enrollment was voluntary,
we could see that the women's compliance for endoscopy screening should be higher than for men. Studies have shown that ESCC and EAC are more common in men than in women. 1, 2, 20 So, the inverse situation indicated a greater need for compliance improvement in men. Besides, enrolled females in the 2 groups both accounted for more than half, which also showed the reality that women may be more willing or have greater opportunities to participate in some public programs. Second, the enrolled intervention group had higher education. This could be easily understood because a more highly educated population may have more health consciousness to participate in screening. As for family history of cancer and income, the difference should come from the information bias. As the questionnaire survey showed that the intervention group was in hospital whereas the control group was in the community, higher income and lower family history of cancer were reported in the control group due to conceal or modify unfavorable information. A previous study reported similar results. 4 For other population characteristics such as smoking, alcohol use, height and weight, although statistically significant, the actual difference that may result from gender or education imbalance was very small, and would not strongly affect the comparability of the 2 groups. All in all, we think that the stage distributions between the 2 groups were generally comparable, even though the 2 populations voluntarily enrolled. Also, the cluster randomization should make the target populations comparable.
To our knowledge, this is the first population-based study to
show TNM stage distributions of esophageal cases worldwide. We indicated the proportions of esophageal cases in each stage, and compared differences between the intervention group and the control group in terms of enrolled or non-enrolled populations and before-intervention or after-intervention periods. By taking the TNM and study-defined stage, but not the previous incidence and mortality, as the endpoint, we again confirmed the efficacy of endoscopy screening. We finally extend the conclusion that screening has an GUAN ET AL.
early detection effect only in the enrolled population, and that screening efficacy in the total target population is determined by compliance. We suppose that the current increase in the proportion of early detection, which resulted from early detection of many preclinical phase cases, is just the beginning. As the aim of screening is not only to detect carcinoma, but also to detect precursor lesions, with close follow up and timely treatments for detected precursor lesions, just as the decrease of incidence and mortality, 4 the subsequent diagnosed esophageal cases from the intervention group will also have a higher early detection proportion than the control group in the enrolled population. As a long-term follow-up cohort, it would be proven in our further study. Also, if such is the case, it will be powerful real-world evidence to support the efficacy of endoscopy screening. 
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